BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38892072)

  • 1. Mechanistic and Structural Insights on Difluoromethyl-1,3,4-oxadiazole Inhibitors of HDAC6.
    Cellupica E; Gaiassi A; Rocchio I; Rovelli G; Pomarico R; Sandrone G; Caprini G; Cordella P; Cukier C; Fossati G; Marchini M; Bebel A; Airoldi C; Palmioli A; Stevenazzi A; Steinkühler C; Vergani B
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase
    König B; Watson PR; Reßing N; Cragin AD; Schäker-Hübner L; Christianson DW; Hansen FK
    J Med Chem; 2023 Oct; 66(19):13821-13837. PubMed ID: 37782298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity.
    Cellupica E; Caprini G; Cordella P; Cukier C; Fossati G; Marchini M; Rocchio I; Sandrone G; Vanoni MA; Vergani B; Źrubek K; Stevenazzi A; Steinkühler C
    J Biol Chem; 2023 Jan; 299(1):102800. PubMed ID: 36528061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6).
    Motlová L; Šnajdr I; Kutil Z; Andris E; Ptáček J; Novotná A; Nováková Z; Havlínová B; Tueckmantel W; Dráberová H; Majer P; Schutkowski M; Kozikowski A; Rulíšek L; Bařinka C
    ACS Chem Biol; 2023 Jul; 18(7):1594-1610. PubMed ID: 37392419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of WO2017018805: 1,3,4-oxadiazole sulfamide derivatives as selective HDAC6 inhibitors.
    Liang YY; Zhang CM; Liu ZP
    Expert Opin Ther Pat; 2018 Aug; 28(8):647-651. PubMed ID: 30073889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of Hydroxamate- and Difluoromethyloxadiazole-Based Inhibitors of Histone Deacetylase 6 In Vitro and in Cells.
    Ptacek J; Snajdr I; Schimer J; Kutil Z; Mikesova J; Baranova P; Havlinova B; Tueckmantel W; Majer P; Kozikowski A; Barinka C
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6.
    Osko JD; Christianson DW
    Acta Crystallogr F Struct Biol Commun; 2020 Sep; 76(Pt 9):428-437. PubMed ID: 32880591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism.
    Ripa L; Sandmark J; Hughes G; Shamovsky I; Gunnarsson A; Johansson J; Llinas A; Collins M; Jung B; Novén A; Pemberton N; Mogemark M; Xiong Y; Li Q; Tångefjord S; Ek M; Åstrand A
    J Med Chem; 2023 Oct; 66(20):14188-14207. PubMed ID: 37797307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
    Porter NJ; Mahendran A; Breslow R; Christianson DW
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the first non-hydroxamate selective HDAC6 degraders.
    Keuler T; König B; Bückreiß N; Kraft FB; König P; Schäker-Hübner L; Steinebach C; Bendas G; Gütschow M; Hansen FK
    Chem Commun (Camb); 2022 Oct; 58(79):11087-11090. PubMed ID: 36098075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.
    Osko JD; Christianson DW
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127023. PubMed ID: 32067866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.
    Leonhardt M; Sellmer A; Krämer OH; Dove S; Elz S; Kraus B; Beyer M; Mahboobi S
    Eur J Med Chem; 2018 May; 152():329-357. PubMed ID: 29738953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(Difluoromethyl)-1,3,4-oxadiazoles: The Future of Selective Histone Deacetylase 6 Modulation?
    König B; Hansen FK
    ACS Pharmacol Transl Sci; 2024 Mar; 7(3):899-903. PubMed ID: 38481687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.
    Vögerl K; Ong N; Senger J; Herp D; Schmidtkunz K; Marek M; Müller M; Bartel K; Shaik TB; Porter NJ; Robaa D; Christianson DW; Romier C; Sippl W; Jung M; Bracher F
    J Med Chem; 2019 Feb; 62(3):1138-1166. PubMed ID: 30645113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6.
    Porter NJ; Wagner FF; Christianson DW
    Biochemistry; 2018 Jul; 57(26):3916-3924. PubMed ID: 29775292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for the expression, purification, and crystallization of histone deacetylase 6-inhibitor complexes.
    Osko JD; Christianson DW
    Methods Enzymol; 2019; 626():447-474. PubMed ID: 31606087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors.
    Ferreira de Freitas R; Harding RJ; Franzoni I; Ravichandran M; Mann MK; Ouyang H; Lautens M; Santhakumar V; Arrowsmith CH; Schapira M
    J Med Chem; 2018 May; 61(10):4517-4527. PubMed ID: 29741882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6.
    Osko JD; Porter NJ; Narayana Reddy PA; Xiao YC; Rokka J; Jung M; Hooker JM; Salvino JM; Christianson DW
    J Med Chem; 2020 Jan; 63(1):295-308. PubMed ID: 31793776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019).
    He X; Li Z; Zhuo XT; Hui Z; Xie T; Ye XY
    Recent Pat Anticancer Drug Discov; 2020; 15(1):32-48. PubMed ID: 32065106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.